Intentar ORO - Gratis
On a wing and a prayer
Business Standard
|October 28, 2024
The Jharkhand Assembly elections will see electors cast their vote on November 13 and 20. SHIKHA CHATURVEDI analyses how food inflation, poverty, and promises are playing out in the fiscally-strained state
The electoral battle in Jharkhand is intensifying as alliances evolve ahead of the Assembly elections. Currently, the coalition of Jharkhand Mukti Morcha (JMM) and Congress governs the state, with Hemant Soren back in the chief minister's seat. The Bharatiya Janata Party (BJP), the principal opposition in the state, aims to improve its performance after losing to the JMM-Congress combine in 2019, following a five-year rule from 2014 to 2019. This year, the BJP has allied with the All Jharkhand Students Union (AJSU).
To attract voters, purse strings are being loosened. The JMM-led government has launched the Mukhyamantri Maiya Samman Yojana (MMSY), providing ₹1,000 per month to eligible women aged 21 to 50. Last month, the state Cabinet lowered the minimum age limit to 18. Currently, 4,815,048 women are registered, with 4,536,597 receiving benefits.
The government plans to increase payouts to ₹2,500 per month in December to further enhance this initiative. This increase, aimed at countering the BJP's proposed 'Gogo Didi Yojana' which promises ₹2,100 per month to women, is expected to hit the state exchequer by ₹9,000 crore a year.
However, financing these initiatives poses challenges, as Jharkhand generates only about 30.8 per cent of its revenue receipts from its own tax collections. Additionally, the state's finances are strained by a comprehensive pension scheme that provides universal coverage, lowering the qualifying age for old-age pensions from 60 to 50 years for marginalized groups, including Dalits, Adivasis, and women. The state government supplements central pension amounts, contributing an additional ₹240.4 crore to ensure all eligible individuals receive ₹1,000 a month.
Esta historia es de la edición October 28, 2024 de Business Standard.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Business Standard
Business Standard
Labour Codes impact: HCL tech profit slips 11%
Q3 top line beats Street estimates, bottom line misses expectations
2 mins
January 13, 2026
Business Standard
New labour Codes, restructuring weigh on TCS earnings
Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.
1 min
January 13, 2026
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS
Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Listen
Translate
Change font size
